Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma
Globally, hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) is one of the major causes of cancer-related mortality. This is, in part, due to delayed diagnosis and limited therapeutic options with more advanced stages of the disease. Given the prognostic importance of early diagnosis, no...
Main Authors: | Vijay Pandyarajan, Rajalakshmi Govalan, Ju Dong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/2/479 |
Similar Items
-
Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development
by: Alessia Virzì, et al.
Published: (2021-03-01) -
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment
by: F. D’Andrea, et al.
Published: (2020-03-01) -
Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
by: Joseph Yoo, et al.
Published: (2018-04-01) -
Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma
by: Mohamed A. Abdel Mohsen, et al.
Published: (2014-09-01) -
High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
by: Jan-Hendrik Bockmann, et al.
Published: (2021-04-01)